These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34174395)

  • 1. Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease.
    Yang X; Chen A; Liang Q; Dong Q; Fu M; Liu X; Wang S; Li Y; Ye Y; Lan Z; Ou JS; Lu L; Yan J
    Free Radic Biol Med; 2021 Aug; 172():530-540. PubMed ID: 34174395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrobium officinale polysaccharide inhibits vascular calcification via anti-inflammatory and anti-apoptotic effects in chronic kidney disease.
    Jiang W; Ruan W; Wang Z
    FASEB J; 2022 Sep; 36(9):e22504. PubMed ID: 35980507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wogonin inhibits oxidative stress and vascular calcification via modulation of heme oxygenase-1.
    Lu L; Li Y; Dong Q; Fang J; Chen A; Lan Z; Ye Y; Yan J; Liang Q
    Eur J Pharmacol; 2023 Nov; 958():176070. PubMed ID: 37739306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification.
    Ye Y; Chen A; Li L; Liang Q; Wang S; Dong Q; Fu M; Lan Z; Li Y; Liu X; Ou JS; Lu L; Yan J
    Kidney Int; 2022 Dec; 102(6):1259-1275. PubMed ID: 36063875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling.
    Su Z; Zong P; Chen J; Yang S; Shen Y; Lu Y; Yang C; Kong X; Sheng Y; Sun W
    J Cell Mol Med; 2020 Nov; 24(21):12476-12490. PubMed ID: 32954678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
    Chen A; Lan Z; Li L; Xie L; Liu X; Yang X; Wang S; Liang Q; Dong Q; Feng L; Li Y; Ye Y; Fu M; Lu L; Yan J
    Cardiovasc Res; 2023 Oct; 119(13):2368-2381. PubMed ID: 37523743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway.
    Liu X; Chen A; Liang Q; Yang X; Dong Q; Fu M; Wang S; Li Y; Ye Y; Lan Z; Chen Y; Ou JS; Yang P; Lu L; Yan J
    Aging Cell; 2021 Jun; 20(6):e13377. PubMed ID: 33969611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling.
    Feng L; Que D; Li Z; Zhong X; Yan J; Wei J; Zhang X; Yang P; Ou C; Chen M
    Clin Sci (Lond); 2021 Nov; 135(21):2483-2502. PubMed ID: 34643227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC42 promotes vascular calcification in chronic kidney disease.
    Li Z; Wu J; Zhang X; Ou C; Zhong X; Chen Y; Lu L; Liu H; Li Y; Liu X; Wu B; Wang Y; Yang P; Yan J; Chen M
    J Pathol; 2019 Dec; 249(4):461-471. PubMed ID: 31397884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt7 protects against vascular calcification via modulation of reactive oxygen species and senescence of vascular smooth muscle cells.
    Yu H; Xie Y; Lan L; Ma S; Mok SWF; Wong IN; Wang Y; Zhong G; Yuan L; Zhao H; Hu X; Macrae VE; He S; Chen G; Zhu D
    Free Radic Biol Med; 2024 Oct; 223():30-41. PubMed ID: 39053861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease.
    Jin D; Lin L; Xie Y; Jia M; Qiu H; Xun K
    FASEB J; 2022 Jan; 36(1):e22098. PubMed ID: 34918390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1.
    Yu X; Tao W; Jiang F; Li C; Lin J; Liu C
    Am J Hypertens; 2010 Aug; 23(8):895-903. PubMed ID: 20414191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Inhibits Vascular Calcification Through Sirtuin 3-Mediated Reduction of Mitochondrial Oxidative Stress.
    Feng H; Wang JY; Yu B; Cong X; Zhang WG; Li L; Liu LM; Zhou Y; Zhang CL; Gu PL; Wu LL
    Antioxid Redox Signal; 2019 Jul; 31(1):75-91. PubMed ID: 30829051
    [No Abstract]   [Full Text] [Related]  

  • 14. Downregulation of HDAC9 by the ketone metabolite β-hydroxybutyrate suppresses vascular calcification.
    Lan Z; Chen A; Li L; Ye Y; Liang Q; Dong Q; Wang S; Fu M; Li Y; Liu X; Zhu Z; Ou JS; Qiu X; Lu L; Yan J
    J Pathol; 2022 Nov; 258(3):213-226. PubMed ID: 35894849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification.
    Agharazii M; St-Louis R; Gautier-Bastien A; Ung RV; Mokas S; Larivière R; Richard DE
    Am J Hypertens; 2015 Jun; 28(6):746-55. PubMed ID: 25430697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals.
    Zhang X; Li Y; Yang P; Liu X; Lu L; Chen Y; Zhong X; Li Z; Liu H; Ou C; Yan J; Chen M
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):751-765. PubMed ID: 31941382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.
    Li KL; Chen J; Li ZH; Zhao L; He YN
    Cardiovasc J Afr; 2012 Jul; 23(6):e1-9. PubMed ID: 22143460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.
    Alesutan I; Feger M; Tuffaha R; Castor T; Musculus K; Buehling SS; Heine CL; Kuro-O M; Pieske B; Schmidt K; Tomaschitz A; Maerz W; Pilz S; Meinitzer A; Voelkl J; Lang F
    Cardiovasc Res; 2016 Jun; 110(3):408-18. PubMed ID: 27001421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
    Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
    Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.